imiquimod has been researched along with Cancer of Pancreas in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Correia, A; Diego-González, L; González-Fernández, Á; Martínez-Pérez, A; Simón-Vázquez, R; Vilanova, M | 1 |
| Donahue, RN; McLaughlin, PJ; Rogosnitzky, M; Zagon, IS | 1 |
2 other study(ies) available for imiquimod and Cancer of Pancreas
| Article | Year |
|---|---|
Immunization with nanovaccines containing mutated K-Ras peptides and imiquimod aggravates heterotopic pancreatic cancer induced in mice.
Topics: Animals; Cancer Vaccines; Imiquimod; Immunization; Mice; Nanocapsules; Pancreatic Neoplasms; Peptides | 2023 |
Imiquimod upregulates the opioid growth factor receptor to inhibit cell proliferation independent of immune function.
Topics: Adenocarcinoma; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Head and Neck Neoplasms; Humans; Imiquimod; Immunity; Narcotic Antagonists; Pancreatic Neoplasms; Receptors, Opioid; RNA, Small Interfering; Up-Regulation | 2008 |